We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+45.33%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$361M
AUM Growth
+$24.6M
Cap. Flow
-$42.3M
Cap. Flow %
-11.73%
Top 10 Hldgs %
20.84%
Holding
153
New
45
Increased
24
Reduced
31
Closed
47

Top Buys

Rank Stock Value
1
CRDO icon
Credo Technology Group
CRDO
+$5.59M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$5.03M
3
MOD icon
Modine Manufacturing
MOD
+$4.87M
4
STRL icon
Sterling Infrastructure
STRL
+$4.85M
5
CELH icon
Celsius Holdings
CELH
+$4.47M

Top Sells

Rank Stock Value
1
PLMR icon
Palomar
PLMR
+$7.93M
2
CWST icon
Casella Waste Systems
CWST
+$6.98M
3
BTSG icon
BrightSpring Health Services
BTSG
+$6.21M
4
KRYS icon
Krystal Biotech
KRYS
+$5.48M
5
MASI
Masimo
MASI
+$5.08M

Sector Composition

Rank Sector Weight
1 Technology 26.37%
2 Industrials 25.9%
3 Healthcare 20.31%
4 Consumer Discretionary 10.72%
5 Consumer Staples 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
26
ADMA Biologics
ADMA
$2.09B
$5.03M 1.39%
275,955
-32,485
-11% -$662K
DAVE icon
27
Dave Inc
DAVE
$5.47B
$4.98M 1.38%
+18,565
New +$2.93M
MP icon
28
MP Materials
MP
$8.59B
$4.98M 1.38%
149,635
+12,930
+9% +$330K
FROG icon
29
JFrog
FROG
$10.4B
$4.84M 1.34%
110,195
+10,230
+10% +$389K
TNDM icon
30
Tandem Diabetes Care
TNDM
$1.35B
$4.73M 1.31%
+253,840
New +$5.03M
TMDX icon
31
Transmedics
TMDX
$2.54B
$4.71M 1.3%
35,130
+6,260
+22% +$687K
FIVE icon
32
Five Below
FIVE
$12.3B
$4.53M 1.25%
+34,500
New +$3.36M
SITM icon
33
SiTime
SITM
$16.6B
$4.51M 1.25%
21,175
+9,355
+79% +$1.69M
KVYO icon
34
Klaviyo
KVYO
$5.85B
$4.45M 1.23%
132,405
+22,150
+20% +$702K
SLAB icon
35
Silicon Laboratories
SLAB
$7.2B
$4.19M 1.16%
+28,450
New +$3.37M
VRNA
36
DELISTED
Verona Pharma
VRNA
$4.16M 1.15%
+43,965
New +$3.26M
AIT icon
37
Applied Industrial Technologies
AIT
$13.2B
$4.08M 1.13%
17,565
-6,270
-26% -$1.43M
XMTR icon
38
Xometry
XMTR
$5.07B
$4.06M 1.13%
120,185
+70,105
+140% +$2.05M
LRN icon
39
Stride
LRN
$3.62B
$4.02M 1.11%
27,695
-13,460
-33% -$1.95M
ONON icon
40
On Holding
ONON
$12.8B
$3.98M 1.1%
+76,435
New +$3.89M
HQY icon
41
HealthEquity
HQY
$8.73B
$3.81M 1.06%
36,345
-10,755
-23% -$1.02M
ALGM icon
42
Allegro MicroSystems
ALGM
$7.84B
$3.76M 1.04%
109,975
+30,920
+39% +$770K
PI icon
43
Impinj
PI
$5.05B
$3.74M 1.04%
+33,635
New +$3.34M
MTZ icon
44
MasTec
MTZ
$21.9B
$3.71M 1.03%
21,775
+3,890
+22% +$560K
LEU icon
45
Centrus Energy
LEU
$3.71B
$3.5M 0.97%
+19,125
New +$2.04M
BROS icon
46
Dutch Bros
BROS
$9.04B
$3.41M 0.95%
49,870
+37,595
+306% +$2.45M
CORT icon
47
Corcept Therapeutics
CORT
$12B
$3.4M 0.94%
46,360
-53,100
-53% -$3.85M
VCEL icon
48
Vericel Corp
VCEL
$2.37B
$3.4M 0.94%
79,935
+40,920
+105% +$1.7M
FOUR icon
49
Shift4
FOUR
$4.37B
$3.35M 0.93%
+33,850
New +$2.95M
CROX icon
50
Crocs
CROX
$6.73B
$3.14M 0.87%
+30,985
New +$3.16M
1
2
3 4 5

Similar funds

GF
Gray Foundation Cohoes, New York $397M AUM 32.69% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
STT
Singapore Technologies Telemedia Singapore $396M AUM 59.06% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Lisanti Capital Growth's Q2 2025 Portfolio in Review

As of Q2 2025, Lisanti Capital Growth held 153 positions worth $361M, up 7.3% from $336M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lisanti Capital Growth withdrew a net $42.3M in Q2 2025, closing 47 positions and reducing 31 holdings. Its most notable exit was Palomar, an estimated $7.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Tandem Diabetes Care worth $4.73M.

  • Lisanti Capital Growth's largest Q2 2025 buy was Tandem Diabetes Care: 253,840 shares worth $4.73M.
  • Lisanti Capital Growth added most to Credo Technology Group in Q2 2025, an estimated $5.59M increase.
  • Lisanti Capital Growth's biggest Q2 2025 reduction was Ligand Pharmaceuticals, cutting an estimated $4.48M.
  • Lisanti Capital Growth fully exited Palomar in Q2 2025, selling an estimated $7.93M.
  • Lisanti Capital Growth's ten largest holdings make up 21% of its $361M portfolio in Q2 2025.
  • Lisanti Capital Growth opened 45 new positions and closed 47 in Q2 2025.
  • Lisanti Capital Growth's portfolio value rose 7.3% quarter-over-quarter to $361M.

Based on Lisanti Capital Growth's 13F filing for Q2 2025, filed 7 Aug 2025.